Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
04/1993
04/12/1993CA2080276A1 Reagent useful for breakingdown and method of use of said reagent
04/12/1993CA2080258A1 Process for the purification of streptolysin o, intact streptolysin o obtainable by this process and its use
04/08/1993CA2079921A1 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use
04/07/1993EP0535959A1 Cyclohexapeptidyl propanolamine compounds
04/07/1993EP0535804A1 Peptide compounds
04/07/1993EP0535336A2 MK protein as cell growth inhibitor
04/07/1993EP0535155A1 Libraries of modified peptides with protease resistance
04/07/1993EP0535151A1 Peptide library and screening systems
04/07/1993EP0535088A1 Chimeric toxins with improved inter-domain geometry
04/07/1993EP0535052A1 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
04/07/1993EP0535007A1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS.
04/07/1993EP0534992A1 Process for producing peptides.
04/07/1993EP0516686A4 Separation by carrier mediated transport
04/07/1993EP0491849A4 A method for the purification of transforming growth factor (tgf-)
04/06/1993US5200910 Method for modelling the electron density of a crystal
04/06/1993US5200546 Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
04/06/1993US5200510 Utilizing a preferential binding peptide bound to an insoluble matrix; elution; collection
04/06/1993US5200507 Using hydrogen fluoride
04/06/1993US5200505 R106 compounds
04/06/1993US5200471 Immobilization on an azlactone-functional polymeric support in the presence of a polyanionic salt buffer and quenching
04/02/1993CA2076830A1 "curculin c"
04/01/1993WO1993006231A1 Anti-human milk fat globule humanised antibodies
04/01/1993WO1993006132A1 Modified peptide derivatives
04/01/1993WO1993006131A1 Porcine adipocyte antigens and their use in the immunological control of fat
04/01/1993WO1993006121A1 Method of synthesizing diverse collections of oligomers
04/01/1993WO1993006116A1 Glial derived neurotrophic factor
04/01/1993WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins
04/01/1993CA2118806A1 Method of synthesizing diverse collections of oligomers
04/01/1993CA2118595A1 Modified peptide derivatives
04/01/1993CA2116033A1 Porcine adipocyte antigens and their use in the immunological control of fat
03/1993
03/31/1993EP0534812A1 Process for purifying factor VIII and preparations so obtained
03/31/1993EP0534764A1 Protein-dimeric polysaccharide conjugate vaccine
03/31/1993EP0534742A1 Anti-human milk fat globule humanised antibodies
03/31/1993EP0534568A2 Human growth hormone analogues and their use
03/31/1993EP0533849A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS
03/31/1993EP0533830A1 Measuring non-dystrophin proteins and diagnosing muscular dystrophy
03/31/1993EP0498801A4 Solid surface for peptide synthesis
03/31/1993EP0470976B1 Processes and compositions for the isolation of human relaxin
03/31/1993EP0281604B1 Single polypeptide chain binding molecules
03/31/1993CA2079290A1 Activities of mk protein
03/30/1993US5198537 Immunogens for immunoassay
03/30/1993US5198534 Process for preparation of activated protein c by immobilized aprotinin chromatography
03/30/1993US5198533 Decapeptides
03/30/1993US5198531 Polymeric resin for peptide synthesis
03/30/1993US5198359 Recombinant protein receptor for il-2
03/30/1993CA1315482C Process for reducing methionine sulfoxide residues
03/30/1993CA1315477C 2-amino acetamide derivatives
03/30/1993CA1315475C Process for producing –-l-aspartyl-l-phenylalanine methyl ester having an improved solubility
03/30/1993CA1315472C Thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein
03/30/1993CA1315470C Allylic side chain-containing solid phase systems, processes for the preparation thereof and the use thereof in solid phase reactions
03/30/1993CA1315231C Kibdelosporangium aridum sk&f-aad-609
03/27/1993CA2077888A1 Method for purifying factor viii and preparations obtained
03/25/1993CA2078359A1 Protein-dimeric polysaccharide conjugate vaccine
03/24/1993EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity
03/24/1993EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof
03/24/1993EP0532693A1 1,4-diamino-2,3-dihydroxybutanes
03/24/1993EP0532587A1 Methods for trans-destabilization of specific proteins in vivo
03/24/1993EP0345315B1 Ps2 protein derivative
03/23/1993US5196516 Pseudorabies virus vaccine
03/23/1993US5196510 Polypeptides
03/23/1993US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen
03/23/1993US5196321 Methods for in vitro cleavage of ubiquitin fusion proteins
03/23/1993US5196316 Enzyme and dna coding therefor
03/23/1993CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r'
03/23/1993CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r'
03/23/1993CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r'
03/23/1993CA1314830C Bar1 secretion signal
03/23/1993CA1314813C Porous solid phases having bioaffinity, a process for preparing porous solid phases having bioaffinity, and their use
03/18/1993WO1993005389A1 Capillary electrophoresis buffer
03/18/1993WO1993005069A1 New isosteric peptides
03/18/1993WO1993005068A1 Selective affinity material, preparation thereof by molecular imprinting, and use of the same
03/18/1993WO1993005067A1 Topical fibrinogen complex
03/18/1993WO1993005065A1 Preparation of peptides by a solid-phase synthesis and intermediates therefor
03/18/1993WO1993004756A1 System for solid phase reactions
03/18/1993WO1993004702A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
03/18/1993CA2117058A1 Topical fibrinogen complex
03/18/1993CA2116527A1 New isosteric peptides
03/18/1993CA2116360A1 System for solid phase reactions
03/18/1993CA2094244A1 Capillary electrophoresis buffer
03/17/1993EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
03/17/1993EP0532465A1 Protein fraction for cosmetic and dermatological care of the skin
03/17/1993EP0531728A1 HSV gD2 Baculovirus expression system
03/17/1993EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan.
03/16/1993US5194596 Production of vascular endothelial cell growth factor
03/16/1993US5194592 Monoclonal antibodies to novel polypeptide derivatives of human granulocyte colony stimulating factor
03/16/1993US5194585 Vasoactive peptides
03/16/1993US5194392 Method of determining mimotopes
03/16/1993CA1314655C Hydroxylamine derivatives
03/16/1993CA1314503C Detectable molecules, method of preparation and use
03/14/1993CA2078087A1 Hsv gd2 baculovirus expression system
03/13/1993CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
03/11/1993DE4129901A1 Affinity carrier for fractionation of bio-polymers - comprises polyamide grafted with vinyl monomer carrying coupling side gps. and monomer with non-coupling gps.
03/10/1993EP0531005A2 Micro-emulsions
03/10/1993EP0530505A2 Hydantoin derivatives
03/10/1993EP0530447A2 Process for purifying IgG monoclonal antibodies and their use
03/10/1993EP0346460B1 Purine derivatives having pharmacological action
03/10/1993EP0315650B1 Purification of recombinant interleukin-1
03/10/1993CN1069736A New isosteric peptides
03/10/1993CN1069735A Rapid synthesis and screening of peptide mimetics
03/09/1993US5192694 Anticoagulant, purification by adsorption on support, immunoadsorbent